Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kösebay

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|January 1, 1988
The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptineT Atasü, D Kösebay, F Aksu
Biological Research in Pregnancy and Perinatology|January 1, 1985
Hyperprolactinemia and its effect on female sterilityT Atasü, D Kösebay, M Arvas
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 2001
A huge abdominal mass mimicking ovarian cancer: p53-negative but aneuploid myxoid leiomyosarcoma of the uterusS Kaleli, Z Calay, N Ceydeli, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 8, 2005
Radical versus conservative surgery for vulvar carcinomaM Arvas, F Köse, A Gezer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?T Beşe, F Demirkiran, M Arvas, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 1, 1996
Appendectomy in the surgical staging of ovarian carcinomaT Beşe, D Kösebay, S Kaleli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 1, 1996
Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifenT Beşe, D Kösebay, F Demirkiran, et al.
Cancer|March 1, 1997
A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fractionS Kaleli, D Kösebay, T Beşe, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2003
Vascular endothelial growth factor in adnexal massesF Demirkiran, B Kumbak, T Bese, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|January 1, 1988
The role of prolactin in luteal inadequacy: treatment of hyperprolactinaemia with bromocriptineT Atasü, D Kösebay, F Aksu
Biological Research in Pregnancy and Perinatology|January 1, 1985
Hyperprolactinemia and its effect on female sterilityT Atasü, D Kösebay, M Arvas
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 1, 2001
A huge abdominal mass mimicking ovarian cancer: p53-negative but aneuploid myxoid leiomyosarcoma of the uterusS Kaleli, Z Calay, N Ceydeli, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 8, 2005
Radical versus conservative surgery for vulvar carcinomaM Arvas, F Köse, A Gezer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?T Beşe, F Demirkiran, M Arvas, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 1, 1996
Appendectomy in the surgical staging of ovarian carcinomaT Beşe, D Kösebay, S Kaleli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 1, 1996
Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifenT Beşe, D Kösebay, F Demirkiran, et al.
Cancer|March 1, 1997
A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fractionS Kaleli, D Kösebay, T Beşe, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2003
Vascular endothelial growth factor in adnexal massesF Demirkiran, B Kumbak, T Bese, et al.
Pageof 1